STOCKHOLDERS’ EQUITY - Schedule of Stock Options (Details) - Stock Options - $ / shares	12 Months Ended
Dec. 31, 2025	Dec. 31, 2024
Number of options
Outstanding as balance (in shares)	3,387,638
Granted (in shares)	2,726,306
Exercised (in shares)	0
Forfeited / expired (in shares)	(192,288)
Outstanding as balance (in shares)	5,921,656	3,387,638
Unvested (in shares)	4,483,397
Exercisable (in shares)	820,253
Weighted average exercise price per share
Outstanding (in dollars per share)	$ 7.82
Granted (in dollars per share)	4.76
Exercised (in dollars per share)	0
Forfeited / expired (in dollars per share)	5.99
Outstanding (in dollars per share)	6.47	$ 7.82
Unvested (in dollars per share)	5.93
Exercisable (in dollars per share)	$ 5.99
Weighted average remaining contractual life (years)	5 years 7 months 6 days	5 years 8 months 12 days
Weighted average remaining contractual life, Granted (years)	7 years
Weighted average remaining contractual life, Unvested (years)	5 years 10 months 24 days
Weighted average remaining contractual life, Exercisable (years)	5 years 4 months 24 days

The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2